Nabiey Romin
SEC CIK 1924892 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | CAO | 185.9K | — | $534.8K | 79 | 2022-07-15 | 2026-03-08 |
Most active insiders at GDRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRANCISCO PARTNERS IV, L.P. | 10% | — | $9.68M |
| 2 | SEA VII Management, LLC | 10% | — | $95.1K |
| 3 | Fengler Justin | See Remarks | — | — |
| 4 | Chan Thomas (TC) | CAO | — | — |
| 5 | Barnes Wendy Lynn | See Remarks, Dir | — | — |
| 6 | Nabiey Romin | CAO | — | — |
| 7 | Hirsch Douglas Joseph | Dir | — | — |
| 8 | Bezdek Trevor | Dir | — | — |
| 9 | McGinnis Christopher A | See Remarks | — | — |
| 10 | Bruehlman Ronald E | Dir | — | — |
Transactions 79
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-09 | 2026-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 185.9K | +7% | — |
| DM | 2026-03-09 | 2026-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $2.28 | -5,121 | 183.1K | -3% | -$11.7K |
| D | 2026-02-17 | 2026-02-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +4,804 | 177.7K | +3% | — |
| D | 2026-02-17 | 2026-02-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $2.18 | -1,979 | 175.7K | -1% | -$4,314 |
| D | 2026-02-09 | 2026-02-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 178.1K | +8% | — |
| D | 2026-02-09 | 2026-02-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $2.44 | -5,215 | 172.9K | -3% | -$12.7K |
| DM | 2025-12-08 | 2025-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $2.71 | -4,449 | 165.5K | -3% | -$12.1K |
| DM | 2025-12-08 | 2025-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 166.3K | +8% | — |
| D | 2025-11-17 | 2025-11-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $2.97 | -1,719 | 156.5K | -1% | -$5,105 |
| D | 2025-11-17 | 2025-11-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +4,804 | 158.2K | +3% | — |
| D | 2025-11-10 | 2025-11-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 157.9K | +9% | — |
| D | 2025-11-10 | 2025-11-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $3.11 | -4,531 | 153.4K | -3% | -$14.1K |
| DM | 2025-09-08 | 2025-09-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.00 | -4,449 | 145.3K | -3% | -$17.8K |
| DM | 2025-09-08 | 2025-09-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 146.1K | +9% | — |
| D | 2025-08-15 | 2025-08-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $3.54 | -1,719 | 137.3K | -1% | -$6,085 |
| D | 2025-08-15 | 2025-08-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +4,804 | 139.0K | +4% | — |
| D | 2025-08-08 | 2025-08-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 138.7K | +10% | — |
| D | 2025-08-08 | 2025-08-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $3.47 | -4,531 | 134.2K | -3% | -$15.7K |
| DM | 2025-06-09 | 2025-06-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.08 | -4,449 | 124.6K | -3% | -$18.2K |
| DM | 2025-06-09 | 2025-06-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 128.3K | +11% | — |
| D | 2025-05-15 | 2025-05-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.27 | -1,719 | 118.1K | -1% | -$7,340 |
| D | 2025-05-15 | 2025-05-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +4,804 | 119.8K | +4% | — |
| D | 2025-05-08 | 2025-05-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 119.5K | +12% | — |
| D | 2025-05-08 | 2025-05-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $3.79 | -4,531 | 115.0K | -4% | -$17.2K |
| DM | 2025-03-10 | 2025-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 107.7K | +13% | — |
| DM | 2025-03-10 | 2025-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.61 | -4,999 | 106.9K | -4% | -$23.0K |
| D | 2025-02-11 | 2025-02-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.84 | -5,202 | 99.4K | -5% | -$25.2K |
| D | 2025-02-11 | 2025-02-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 104.6K | +14% | — |
| D | 2025-01-15 | 2025-01-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.15 | -1,071 | 92.0K | -1% | -$4,445 |
| D | 2025-01-15 | 2025-01-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 93.0K | +3% | — |
| DM | 2024-12-09 | 2024-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 92.6K | +15% | — |
| DM | 2024-12-09 | 2024-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.91 | -4,437 | 90.4K | -5% | -$21.8K |
| D | 2024-11-12 | 2024-11-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.04 | -4,519 | 82.4K | -5% | -$22.8K |
| D | 2024-11-12 | 2024-11-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 87.0K | +17% | — |
| D | 2024-10-18 | 2024-10-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 75.2K | +4% | — |
| D | 2024-10-18 | 2024-10-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $6.91 | -930 | 74.3K | -1% | -$6,426 |
| DM | 2024-09-09 | 2024-09-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 73.4K | +20% | — |
| DM | 2024-09-09 | 2024-09-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $7.71 | -4,437 | 72.6K | -6% | -$34.2K |
| 2024-08-14 | 2024-08-12 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | S - Sale | $6.77 | -79.0K | 64.6K | -55% | -$534.8K | |
| D | 2024-08-08 | 2024-08-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 148.2K | +9% | — |
| D | 2024-08-08 | 2024-08-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $8.61 | -4,519 | 143.6K | -3% | -$38.9K |
| D | 2024-07-15 | 2024-07-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 136.4K | +2% | — |
| D | 2024-07-15 | 2024-07-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $7.71 | -930 | 135.5K | -0.7% | -$7,170 |
| DM | 2024-06-10 | 2024-06-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $8.55 | -4,437 | 133.8K | -3% | -$37.9K |
| DM | 2024-06-10 | 2024-06-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.4K | 134.6K | +10% | — |
| D | 2024-05-08 | 2024-05-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 130.3K | +11% | — |
| D | 2024-05-08 | 2024-05-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $7.53 | -4,518 | 125.8K | -3% | -$34.0K |
| D | 2024-04-16 | 2024-04-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $6.83 | -930 | 117.7K | -0.8% | -$6,352 |
| D | 2024-04-16 | 2024-04-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 118.6K | +2% | — |
| D | 2024-03-08 | 2024-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +10.2K | 119.7K | +9% | — |
| D | 2024-03-08 | 2024-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $7.54 | -3,745 | 116.0K | -3% | -$28.2K |
| D | 2024-02-08 | 2024-02-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $6.22 | -5,190 | 109.5K | -5% | -$32.3K |
| D | 2024-02-08 | 2024-02-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 114.7K | +12% | — |
| D | 2024-01-16 | 2024-01-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 103.1K | +3% | — |
| D | 2024-01-16 | 2024-01-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $6.64 | -1,068 | 102.1K | -1% | -$7,092 |
| D | 2023-12-08 | 2023-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.94 | -3,528 | 100.5K | -3% | -$21.0K |
| D | 2023-12-08 | 2023-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +10.2K | 104.1K | +11% | — |
| D | 2023-11-08 | 2023-11-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 98.2K | +15% | — |
| D | 2023-11-08 | 2023-11-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.40 | -4,379 | 93.9K | -4% | -$23.6K |
| D | 2023-10-17 | 2023-10-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 86.5K | +3% | — |
| D | 2023-10-17 | 2023-10-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.31 | -902 | 85.6K | -1% | -$4,790 |
| D | 2023-09-08 | 2023-09-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $6.16 | -3,528 | 83.9K | -4% | -$21.7K |
| D | 2023-09-08 | 2023-09-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +10.2K | 87.4K | +13% | — |
| D | 2023-08-10 | 2023-08-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +12.7K | 81.6K | +18% | — |
| D | 2023-08-10 | 2023-08-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $8.68 | -4,379 | 77.2K | -5% | -$38.0K |
| D | 2023-07-18 | 2023-07-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 69.8K | +4% | — |
| D | 2023-07-18 | 2023-07-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $7.46 | -902 | 68.9K | -1% | -$6,729 |
| D | 2023-06-12 | 2023-06-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +10.2K | 70.7K | +17% | — |
| D | 2023-06-12 | 2023-06-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.41 | -3,528 | 67.2K | -5% | -$19.1K |
| D | 2023-04-18 | 2023-04-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 61.4K | +4% | — |
| D | 2023-04-18 | 2023-04-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.95 | -902 | 60.5K | -1% | -$5,367 |
| D | 2023-03-09 | 2023-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +10.2K | 63.0K | +19% | — |
| D | 2023-03-09 | 2023-03-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.50 | -4,160 | 58.8K | -7% | -$22.9K |
| D | 2023-01-17 | 2023-01-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +2,606 | 53.9K | +5% | — |
| D | 2023-01-17 | 2023-01-15 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.27 | -1,063 | 52.8K | -2% | -$5,602 |
| D | 2022-12-12 | 2022-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +10.2K | 54.8K | +23% | — |
| D | 2022-12-12 | 2022-12-08 | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $4.98 | -3,528 | 51.2K | -6% | -$17.6K |
| DM | 2022-10-18 | 2022-07-15+ | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | F - Tax | $5.45 | -1,804 | 44.6K | -4% | -$9,832 |
| DM | 2022-10-18 | 2022-07-15+ | GDRX | GoodRx Holdings, Inc. | Nabiey Romin | CAO | M - OptEx | — | +5,212 | 45.5K | +13% | — |
Purchase Sale Sale after option exercise All abbreviations